A Novel Population of Expanded Human CD3<sup>+</sup>CD56<sup>+</sup> Cells Derived from T Cells with Potent In Vivo Antitumor Activity in Mice with Severe Combined Immunodeficiency.

LU P-H; NEGRIN R S

Art

J-GLOBAL ID：200902145593461629 Reference number：94A0801292

A Novel Population of Expanded Human CD3⁺CD56⁺ Cells Derived from T Cells with Potent In Vivo Antitumor Activity in Mice with Severe Combined Immunodeficiency.

重症複合免疫不全症マウスにおいて強力なin vivo抗腫よう活性を持つT細胞由来の増加したヒトCD3⁺CD56⁺細胞の新しい集団

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=94A0801292&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=94A0801292&from=J-GLOBAL&jstjournalNo=H0775A") }}

Author (2)： ,
Material：
Volume： 153 Issue： 4 Page： 1687-1696 Publication year： Aug. 15, 1994
JST Material Number： H0775A ISSN： 0022-1767 CODEN： JOIMA3 Document type： Article
Article type：原著論文 Country of issue： United States (USA) Language： ENGLISH (EN)

,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=94A0801292&from=J-GLOBAL&jstjournalNo=H0775A") }}

Tumor immunity

, , , , , ,

Return to Previous Page

A Novel Population of Expanded Human CD3+CD56+ Cells Derived from T Cells with Potent In Vivo Antitumor Activity in Mice with Severe Combined Immunodeficiency.

A Novel Population of Expanded Human CD3⁺CD56⁺ Cells Derived from T Cells with Potent In Vivo Antitumor Activity in Mice with Severe Combined Immunodeficiency.